ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 778 filers reported holding ASTRAZENECA PLC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,720 | -5.6% | 40,166 | -0.2% | 1.29% | -5.6% |
| Q2 2023 | $2,881 | -0.3% | 40,259 | -3.3% | 1.36% | -7.4% |
| Q1 2023 | $2,889 | -7.7% | 41,616 | -9.9% | 1.47% | -13.8% |
| Q4 2022 | $3,131 | -99.9% | 46,183 | +1.6% | 1.71% | +0.1% |
| Q3 2022 | $2,493,000 | -17.5% | 45,454 | -0.6% | 1.71% | -6.9% |
| Q2 2022 | $3,022,000 | 0.0% | 45,744 | +0.4% | 1.83% | +17.0% |
| Q1 2022 | $3,022,000 | +17.5% | 45,559 | +3.2% | 1.57% | +29.9% |
| Q4 2021 | $2,572,000 | -1.0% | 44,152 | +2.1% | 1.21% | -9.4% |
| Q3 2021 | $2,597,000 | +20.5% | 43,238 | +20.2% | 1.33% | +18.6% |
| Q2 2021 | $2,155,000 | +29.4% | 35,984 | +7.4% | 1.12% | +21.2% |
| Q1 2021 | $1,665,000 | +14.4% | 33,491 | +15.0% | 0.93% | +8.9% |
| Q4 2020 | $1,456,000 | -13.1% | 29,121 | -4.8% | 0.85% | -20.1% |
| Q3 2020 | $1,676,000 | +6.6% | 30,592 | +2.9% | 1.06% | -5.5% |
| Q2 2020 | $1,572,000 | -1.1% | 29,724 | -6.8% | 1.13% | -0.9% |
| Q4 2019 | $1,590,000 | – | 31,899 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |